Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

003000.KS


Top 10 Correlated ETFs

003000.KS


Top 10 Correlated Stocks

003000.KS


Financial details

Company Rating
Buy
Market Cap
567.49B
Income
24.54M
Revenue
181.55B
Book val./share
3715.17
Cash/share
1248.94
Dividend
100
Dividend %
1.31%
Employees
571
Optionable
No
Shortable
Yes
Earnings
10 Nov 2022
P/E
21775.78
Forward P/E
-
PEG
-2238.51
P/S
2.94
P/B
2.05
P/C
6.09
P/FCF
14.42
Quick Ratio
2.5
Current Ratio
6.06
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-3.13
EPS next Y
-
EPS next Q
-
EPS this Y
-92.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
3.9%
Revenue Q/Q
16.13%
EPS Q/Q
-91.11%
-
-
-
-
SMA20
-11.93%
SMA50
-5.21%
SMA100
-30.57%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
0.06%
Gross Margin
42%
Oper. Margin
12%
Profit Margin
-
Payout
28615%
Shs Outstand
68.45M
Shs Float
43.01M
-
-
-
-
Target Price
-
52W Range
7880.0-22400.0
52W High
-66.03%
52W Low
-3.43%
RSI
22.78
Rel Volume
0.36
Avg Volume
774.79K
Volume
277.61K
Perf Week
-10.26%
Perf Month
-21.38%
Perf Quarter
-40.31%
Perf Half Y
-38.88%
-
-
-
-
Beta
-0.214957
-
-
Volatility
248.28%, 555.16%
Prev Close
-2.56%
Price
7610
Change
-3.67%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
2.42K3.49K2.46K2.72K1.74K
Net income per share
177.742.61K-108.5-115.45-8.74
Operating cash flow per share
137.23122.32-342.6411.59252.86
Free cash flow per share
32.6155.45-414.45-19.73245.34
Cash per share
387.171.8K550.171.44K803.41
Book value per share
3.39K7.42K4.78K4.14K2.57K
Tangible book value per share
3.17K7.26K4.63K4.23K2.6K
Share holders equity per share
3.39K7.42K4.78K4.14K2.57K
Interest debt per share
0031.75369.6328.28
Market cap
1184.35B1097.7B869.46B1397.55B1111.93B
Enterprise value
1160.2B997.3B833.96B1339.81B1030.71B
P/E ratio
106.797.54-117.3-194.02-1.21K
Price to sales ratio
7.865.655.178.246.09
POCF ratio
138.32161.03-37.141.93K41.92
PFCF ratio
582.07355.23-30.71-1.14K43.21
P/B Ratio
5.612.662.675.414.12
PTB ratio
5.612.662.675.414.12
EV to sales
7.75.134.967.95.65
Enterprise value over EBITDA
55.295.04181.64589.0686.48
EV to operating cash flow
135.5146.3-35.631.85K38.86
EV to free cash flow
570.19322.74-29.45-1.09K40.05
Earnings yield
0.010.13-0.01-0.010
Free cash flow yield
00-0.0300.02
Debt to equity
000.0100
Debt to assets
0.110.160.160.320.3
Net debt to EBITDA
-1.15-0.51-7.73-25.39-6.81
Current ratio
6.465.795.194.065.95
Interest coverage
00104.982.663.99
Income quality
0.770.053.16-0.1-28.94
Dividend Yield
0.020.010.010.010.01
Payout ratio
1.620.06-1.32-1.69-6.79
Sales general and administrative to revenue
0.040.040.040.030.02
Research and developement to revenue
0.170.130.10.110.12
Intangibles to total assets
0.060.020.030.020.02
Capex to operating cash flow
-0.76-0.550.21-2.7-0.03
Capex to revenue
-0.04-0.02-0.03-0.010
Capex to depreciation
-1.07-0.54-0.84-0.32-0.16
Stock based compensation to revenue
0000.020
Graham number
3.68K20.89K3.41K3.28K710.86
ROIC
0.040.080.030.010.02
Return on tangible assets
0.050.3-0.02-0.020
Graham Net
305.12669.96-35.06-232.4-128.04
Working capital
105.08B183.39B150.51B187B183.1B
Tangible asset value
198B404.47B316.1B264.19B273.08B
Net current asset value
99.4B141.46B124.35B118.43B102.74B
Invested capital
000.010.080.01
Average receivables
00000
Average payables
7.42B7.25B10.02B10.16B8.79B
Average inventory
45.49B42.8B47.76B51.37B45.33B
Days sales outstanding
00000
Days payables outstanding
24.37204337.8225.38
Days of inventory on hand
206.22157.67191.91191.31134.38
Receivables turnover
00000
Payables turnover
14.9718.258.499.6514.38
Inventory turnover
1.772.311.91.912.72
ROE
0.050.35-0.02-0.030
Capex per share
-104.62-66.87-71.81-31.32-7.53

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
658.37717.81.72K1.17K610.38
Net income per share
-49.8760.75-67.48-6
Operating cash flow per share
-109.63284.7304.01453.59-62.01
Free cash flow per share
-111.2278.7301.04446-70.87
Cash per share
1.24K02.68K01.25K
Book value per share
3.72K3.74K8.58K8.28K3.72K
Tangible book value per share
3.8K3.92K8.69K8.59K3.75K
Share holders equity per share
3.72K3.74K8.58K8.28K3.72K
Interest debt per share
326.45049.61.6727.96
Market cap
1349.2B999.41B405.33B400.62B594.17B
Enterprise value
1288.51B999.41B324.11B400.62B509.71B
P/E ratio
-1.27K380.0553.08-47.23-352.5
Price to sales ratio
30.7620.97.5110.8513.86
POCF ratio
-184.7152.6942.4328.11-136.43
PFCF ratio
-182.153.8242.8528.59-119.38
P/B Ratio
5.444.011.51.542.28
PTB ratio
5.444.011.51.542.28
EV to sales
29.3720.96.0110.8511.89
Enterprise value over EBITDA
9.03K302.6946.7-557.89210.41
EV to operating cash flow
-176.452.6933.9328.11-117.04
EV to free cash flow
-173.9153.8234.2628.59-102.41
Earnings yield
000-0.010
Free cash flow yield
-0.010.020.020.03-0.01
Debt to equity
0.010000
Debt to assets
0.320.290.30.310.3
Net debt to EBITDA
-425.110-11.70-34.87
Current ratio
4.396.675.955.26.06
Interest coverage
000-37.8-0.79
Income quality
27.4128.855-6.7210.33
Dividend Yield
0000.020
Payout ratio
000-3.230
Sales general and administrative to revenue
0.260.350.020.480.3
Research and developement to revenue
0.1300.100.15
Intangibles to total assets
0.0200.0200.02
Capex to operating cash flow
0.01-0.02-0.01-0.020.14
Capex to revenue
0-0.010-0.01-0.01
Capex to depreciation
-0.08-0.33-0.08-0.22-0.57
Stock based compensation to revenue
00000
Graham number
578.9911.543.42K3.55K708.2
ROIC
00.060.01-0.010
Return on tangible assets
000-0.010
Graham Net
-225.68-1.58K-427.46-3.89K-79.47
Working capital
182.82B186.09B183.1B174.85B177.2B
Tangible asset value
252.87B0273.08B0263.39B
Net current asset value
112.66B113.83B102.74B94.22B96.83B
Invested capital
0.0900.0100
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
37.44021.1040.68
Days of inventory on hand
176.360111.750164.94
Receivables turnover
00000
Payables turnover
2.404.2602.21
Inventory turnover
0.5100.8100.55
ROE
000.01-0.010
Capex per share
-1.57-6-2.97-7.59-8.86

Frequently Asked Questions

What is Bukwang Pharmaceutical Co., Ltd. stock symbol ?

Bukwang Pharmaceutical Co., Ltd. is a US stock and trading under the symbol 003000.KS

What is Bukwang Pharmaceutical Co., Ltd. stock quote today ?

Bukwang Pharmaceutical Co., Ltd. stock price is $7610 today.

Is Bukwang Pharmaceutical Co., Ltd. stock public?

Yes, Bukwang Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks